Cargando…

In Vitro Pharmacodynamics and Bactericidal Mechanism of Fungal Defensin-Derived Peptides NZX and P2 against Streptococcus agalactiae

(1) Background: Based on the hazard of Streptococcus agalactiae to human and animal health and the increasing drug resistance, it is urgent to develop new antimicrobial agents with high bactericidal activity and low drug resistance against S. agalactiae. This study aims to investigate in vitro pharm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yankang, Yang, Na, Mao, Ruoyu, Hao, Ya, Teng, Da, Wang, Jianhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142981/ https://www.ncbi.nlm.nih.gov/pubmed/35630326 http://dx.doi.org/10.3390/microorganisms10050881

Ejemplares similares

Pharmacokinetics and Pharmacodynamics of Fungal Defensin NZX Against Staphylococcus aureus-Induced Mouse Peritonitis Model
por: Zheng, Xueling, et al.
Publicado: (2022)

Design and Pharmacodynamics of Recombinant Fungus Defensin NZL with Improved Activity against Staphylococcus hyicus In Vitro and In Vivo
por: Liu, He, et al.
Publicado: (2021)

The Pharmacodynamics Study of Insect Defensin DLP4 Against Toxigenic Staphylococcus hyicus ACCC 61734 in Vitro and Vivo
por: Ma, Xuanxuan, et al.
Publicado: (2021)

Molecular Modification of Kex2 P1’ Site Enhances Expression and Druggability of Fungal Defensin
por: Jin, Yanjie, et al.
Publicado: (2023)

Effective delivery of the anti-mycobacterial peptide NZX in mesoporous silica nanoparticles
por: Tenland, Erik, et al.
Publicado: (2019)

Recombinant of the Staphylococcal Bacteriophage Lysin CHAP(k) and Its Elimination against Streptococcus agalactiae Biofilms
por: Shan, Yuxue, et al.
Publicado: (2020)

Development of chimeric peptides to facilitate the neutralisation of lipopolysaccharides during bactericidal targeting of multidrug-resistant Escherichia coli
por: Wang, Zhenlong, et al.
Publicado: (2020)

The pharmacokinetics and pharmacodynamics of cefquinome against Streptococcus agalactiae in a murine mastitis model
por: Yang, Qingwen, et al.
Publicado: (2023)

Streptococcus agalactiae
por: Faro, Sebastian
Publicado: (1993)

Interspecies Interactions Between Streptococcus Mutans and Streptococcus Agalactiae in vitro
por: Liu, Tingjun, et al.
Publicado: (2020)

Design and High Expression of Non-glycosylated Lysostaphins in Pichia pastoris and Their Pharmacodynamic Study
por: Shen, Wenluan, et al.
Publicado: (2021)

Site Mutation Improves the Expression and Antimicrobial Properties of Fungal Defense
por: Hao, Ya, et al.
Publicado: (2023)

The essential genome of Streptococcus agalactiae
por: Hooven, Thomas A., et al.
Publicado: (2016)

Antibacterial and immunomodulatory activities of insect defensins-DLP2 and DLP4 against multidrug-resistant Staphylococcus aureus
por: Li, Zhanzhan, et al.
Publicado: (2017)

The capsule of Bacillus anthracis protects it from the bactericidal activity of human defensins and other cationic antimicrobial peptides
por: O’Brien, David K., et al.
Publicado: (2022)

Streptococcus agalactiae spondylodiscitis in an immunocompetent adult
por: da Costa, Paula Pires, et al.
Publicado: (2023)

In vitro and in vivo antibacterial effect of NZ2114 against Streptococcus suis type 2 infection in mice peritonitis models
por: Jiao, Jian, et al.
Publicado: (2017)

In vitro/vivo Mechanism of Action of MP1102 With Low/Nonresistance Against Streptococcus suis Type 2 Strain CVCC 3928
por: Zhao, Fei, et al.
Publicado: (2019)

The Fungal Defensin Family Enlarged
por: Wu, Jiajia, et al.
Publicado: (2014)

Conserved and specific features of Streptococcus pyogenes and Streptococcus agalactiae transcriptional landscapes
por: Rosinski-Chupin, Isabelle, et al.
Publicado: (2019)

A Review on the Use of Antimicrobial Peptides to Combat Porcine Viruses
por: Pen, Guihong, et al.
Publicado: (2020)

Design and pharmacodynamics of recombinant NZ2114 histidine mutants with improved activity against methicillin-resistant Staphylococcus aureus
por: Chen, Huixian, et al.
Publicado: (2017)

Frequencies and characteristics of genome-wide recombination in Streptococcus agalactiae, Streptococcus pyogenes, and Streptococcus suis
por: Lee, Isaiah Paolo A., et al.
Publicado: (2022)

Mycobacterium abscessus Opsonization Allows an Escape from the Defensin Bactericidal Action in Drosophila
por: Touré, Hamadoun, et al.
Publicado: (2023)

C-terminal mini-PEGylation of a marine peptide N6 had potent antibacterial and anti-inflammatory properties against Escherichia coli and Salmonella strains in vitro and in vivo
por: Li, Ting, et al.
Publicado: (2022)

Effect of NZ2114 against Streptococcus dysgalactiae biofilms and its application in murine mastitis model
por: Yang, Na, et al.
Publicado: (2022)

Thinking on the Construction of Antimicrobial Peptide Databases: Powerful Tools for the Molecular Design and Screening
por: Zhang, Kun, et al.
Publicado: (2023)

Evaluation of the antibacterial activity of tilmicosin-SLN against Streptococcus agalactiae: in vitro and in vivo studies
por: Zhu, Luyan, et al.
Publicado: (2018)

Remodeling of the Streptococcus agalactiae Transcriptome in Response to Growth Temperature
por: Mereghetti, Laurent, et al.
Publicado: (2008)

Correlation of Serotypes and Genotypes of Macrolide-Resistant Streptococcus agalactiae
por: Uh, Young, et al.
Publicado: (2005)

Human Streptococcus agalactiae strains in aquatic mammals and fish
por: Delannoy, Christian MJ, et al.
Publicado: (2013)

Proteomic Biomarkers Associated with Streptococcus agalactiae Invasive Genogroups
por: Lanotte, Philippe, et al.
Publicado: (2013)

Immunogenic Properties of Streptococcus agalactiae FbsA Fragments
por: Papasergi, Salvatore, et al.
Publicado: (2013)

Draft Genome Sequence of Streptococcus agalactiae PR06
por: MZ, Irma Syakina, et al.
Publicado: (2013)

Inapparent Streptococcus agalactiae infection in adult/commercial tilapia
por: Sun, Jiufeng, et al.
Publicado: (2016)

Real-time PCR-based serotyping of Streptococcus agalactiae
por: Breeding, Kathleen M., et al.
Publicado: (2016)

Endogenous endophthalmitis caused by Streptococcus agalactiae: An ophthalmologic emergency
por: Nakai, Takehiro, et al.
Publicado: (2019)

Transcriptomic analysis of Streptococcus agalactiae periprosthetic joint infection
por: Cho, Hye‐Kyung, et al.
Publicado: (2021)

Mania: An atypical presentation of probable Streptococcus agalactiae meningoencephalitis
por: Hudson, Ann, et al.
Publicado: (2023)

The Clinical and Genetic Characteristics of Streptococcus agalactiae Meningitis in Neonates
por: Hsu, Jen-Fu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_edcc4j5ddnleg1fifnp0hgo9p5